ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX (R)) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM

Carlos, F; Guzman, J; Naranjo, M; Carmona, M

VALUE IN HEALTH, 2019; 22 (): S81